Registry for people with eosinophilic esophagitis
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This is a registry (like a medical diary) for people with EoE who are getting regular treatment. It helps doctors track how EoE affects people over time, so they can improve care for everyone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of eosinophilic esophagitis (EoE) from your doctor.
- You should be currently receiving standard treatments for EoE, such as diet changes or medications.
- You must be willing to sign a form allowing us to collect your health information for the registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children ages 0–18 with eosinophilic gut disorders (EGIDs) to better understand these conditions and how they are managed. It may help doctors improve care by comparing real-world information from patients followed at participating hospitals.
This study builds a registry of children with eosinophilic gastrointestinal (gut) disorders (EGIDs) and also includes children being evaluated for possible EGIDs. It may help doctors better understand these conditions and improve future care.
This registry aims to collect information from people who already have a diagnosed food allergy. Joining may help researchers better understand food allergy patterns and needs.
This trial tests an intervention meant to improve how well adults with eosinophilic esophagitis (EoE) follow their ongoing treatment plan. It may help you stay on your medicine and get better symptom control by making adherence easier.
This study looks at how to improve care for people with eosinophilic esophagitis (EoE), a condition that causes inflammation in the esophagus. It may help you if you have or are being checked for EoE.
This study looks at how eosinophilic inflammation in the esophagus and intestines affects outcomes like symptoms and test findings. It may help clinicians better understand these conditions and track what changes over time.
Hear when a new Eosinophilic Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.